|
Market Closed -
Euronext Paris
11:55:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 0.2890 EUR | +1.94% |
|
+1.58% | -14.24% |
| Market Cap | 149M 172M 139M 127M 239M 16.38B 243M 1.64B 641M 8.2B 644M 630M 27.35B | P/E 2026 * |
-38.5x | P/E 2027 * | -6.42x |
|---|---|---|---|---|---|
| Enterprise Value | 16.75M 19.33M 15.71M 14.32M 26.95M 1.84B 27.38M 185M 72.2M 923M 72.57M 70.99M 3.08B | EV / Sales 2026 * |
0.77x | EV / Sales 2027 * | 23.3x |
| Free-Float |
70.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.94% | ||
| 1 week | +1.58% | ||
| Current month | +1.76% | ||
| 1 month | +11.15% | ||
| 3 months | -32.79% | ||
| 6 months | -14.50% | ||
| Current year | -14.24% |
| 1 week | 0.28 |  | 0.3 |
| 1 month | 0.25 | | 0.31 |
| Current year | 0.22 | | 0.81 |
| 1 year | 0.22 | | 0.81 |
| 3 years | 0.15 | | 1.04 |
| 5 years | 0.15 | | 2.29 |
| 10 years | 0.15 | | 7.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 59 | 2026-05-31 |
Laurene Danon
DFI | Director of Finance/CFO | - | 2024-06-25 |
Bernd Schmidt
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2015-03-08 | |
Julien Miara
BRD | Director/Board Member | 43 | - |
Khalil Barrage
CHM | Chairman | 61 | 2023-03-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/6/26 | Redmile Biopharma Investments III LP
| Buy | Company | 18,928,571 | 6.2956% | |
| 1/31/26 | Sofinnova Partners SAS
| Buy | Company | 10,714,285 | 3.5636% | |
| 4/18/24 | Redmile Biopharma Investments III LP
| Buy | Company | 2,781,914 | 1.0091% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.94% | +1.58% | -9.97% | -21.89% | 168M | |
| +1.17% | +1.09% | +4.03% | +15.74% | 48.72B | |
| -1.59% | +2.12% | +460.02% | +573.56% | 43.99B | |
| -0.85% | +7.95% | +15.77% | +80.09% | 40.82B | |
| -0.08% | +3.91% | +26.96% | +9.86% | 39.79B | |
| 0.00% | +3.59% | +20.51% | +48.00% | 32.7B | |
| -2.52% | -0.52% | +24.35% | +118.05% | 16.66B | |
| -3.61% | -1.45% | - | - | 16.84B | |
| +0.72% | +0.31% | +4.94% | +21.70% | 13.95B | |
| -1.09% | +5.94% | +81.46% | +31.15% | 13.58B | |
| Average | -0.59% | +2.05% | +69.79% | +97.36% | 26.72B | |
| Weighted average by Cap. | -0.59% | +2.44% | +97.46% | +135.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.86M 25.22M 20.49M 18.68M 35.15M 2.41B 35.72M 241M 94.19M 1.2B 94.67M 92.62M 4.02B | 6.4M 7.38M 5.99M 5.47M 10.29M 704M 10.45M 70.59M 27.56M 352M 27.7M 27.1M 1.18B |
| Net income | -237K -273K -222K -202K -381K -26.06M -387K -2.61M -1.02M -13.04M -1.03M -1M -43.51M | -36.12M -41.67M -33.86M -30.87M -58.09M -3.98B -59.02M -399M -156M -1.99B -156M -153M -6.64B |
| Net Debt | -132M -152M -124M -113M -212M -14.53B -216M -1.46B -569M -7.28B -572M -559M -24.27B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | €0.2890 | +1.94% | 1,142,885 |
| 26-08-12 | €0.2835 | -2.24% | 716,555 |
| 26-08-11 | €0.2900 | -0.85% | 572,034 |
| 26-08-10 | €0.2925 | +1.21% | 562,204 |
| 26-08-07 | €0.2890 | +1.58% | 720,450 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALSEN Stock
Select your edition
All financial news and data tailored to specific country editions
